Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000905718-21-000288
Filing Date
2021-02-16
Accepted
2021-02-16 16:34:41
Documents
1
Group Members
PARK WEST INVESTORS MASTER FUND, LTDPETER S. PARK

Document Format Files

Seq Description Document Type Size
1 SC 13G/A eagle_13gam4dec312020.htm SC 13G/A 67301
  Complete submission text file 0000905718-21-000288.txt   68993
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Subject) CIK: 0000827871 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88022 | Film No.: 21639460
SIC: 2834 Pharmaceutical Preparations

Mailing Address 900 LARKSPUR LANDING CIRCLE, SUITE 165 LARKSPUR CA 94939
Business Address 900 LARKSPUR LANDING CIRCLE, SUITE 165 LARKSPUR CA 94939 (415) 524-2902
Park West Asset Management LLC (Filed by) CIK: 0001386928 (see all company filings)

EIN.: 300132084 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A